Immunization, HepB3 in North America
North America: Immunization, HepB3 was 92.1% in 2024. ◆ Volatile
Immunization, HepB3 in North America, 1985–2024
Source: World Health Organization (WHO). Measured in % of one-year-old children.
Analysis
North America recorded 92.1% for immunization, hepb3 in 2024. That is the highest value across all 40 years on record.
Compared with earlier readings it is up 3.8% over ten years.
Over the whole period, immunization, hepb3 in North America peaked at 92.1% in 2024 and was at its lowest, 0.0%, in 1985.
That places North America 6th out of 47 groups with data for 2024, putting it in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Immunization, HepB3 in North America, year by year
| Year | % of one-year-old children | Change |
|---|---|---|
| 1985 | 0.0% | — |
| 1986 | 0.0% | — |
| 1987 | 0.0% | — |
| 1988 | 0.0% | — |
| 1989 | 0.0% | — |
| 1990 | 0.0% | — |
| 1991 | 0.0% | — |
| 1992 | 0.0% | — |
| 1993 | 14.5% | — |
| 1994 | 38.2% | +162.6% |
| 1995 | 61.8% | +61.9% |
| 1996 | 74.5% | +20.5% |
| 1997 | 76.3% | +2.5% |
| 1998 | 79.3% | +3.9% |
| 1999 | 80.5% | +1.5% |
| 2000 | 82.5% | +2.5% |
| 2001 | 81.7% | -0.9% |
| 2002 | 81.0% | -0.9% |
| 2003 | 85.8% | +5.9% |
| 2004 | 85.8% | -0.0% |
| 2005 | 86.7% | +1.0% |
| 2006 | 86.7% | -0.0% |
| 2007 | 86.7% | +0.0% |
| 2008 | 88.7% | +2.3% |
| 2009 | 87.9% | -0.9% |
| 2010 | 88.9% | +1.2% |
| 2011 | 89.2% | +0.3% |
| 2012 | 88.2% | -1.1% |
| 2013 | 87.8% | -0.5% |
| 2014 | 88.7% | +1.0% |
| 2015 | 90.0% | +1.4% |
| 2016 | 91.0% | +1.1% |
| 2017 | 89.2% | -1.9% |
| 2018 | 89.2% | -0.0% |
| 2019 | 90.4% | +1.3% |
| 2020 | 90.4% | -0.0% |
| 2021 | 91.3% | +1.0% |
| 2022 | 92.1% | +0.9% |
| 2023 | 92.1% | +0.0% |
| 2024 | 92.1% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 0.0% | 0.0% | 0.0% | 5 |
| 1990s | 42.5% | 0.0% | 80.5% | 10 |
| 2000s | 85.4% | 81.0% | 88.7% | 10 |
| 2010s | 89.3% | 87.8% | 91.0% | 10 |
| 2020s | 91.6% | 90.4% | 92.1% | 5 |
More health data for North America
- Population ages 65-69, male, per capita 0.0282 units per person (2025)
- Population ages 70-74, male, per capita 0.0227 units per person (2025)
- Population ages 70-74, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 70-74, male, annual growth rate 3.25 % change on previous year (2025)
- Population ages 70-74, female, per capita 0.0253 units per person (2025)
- Population ages 70-74, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 70-74, female, annual growth rate 3.1 % change on previous year (2025)
- Population ages 65-69, female, annual growth rate 1.32 % change on previous year (2025)
- Population ages 65-69, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65-69, female, per capita 0.0299 units per person (2025)
Frequently asked questions
- What is immunization, hepb3 in North America?
- Immunization, hepb3 in North America was 92.1% in 2024, according to World Health Organization (WHO).
- What is the highest immunization, hepb3 recorded in North America?
- The highest recorded value was 92.1% in 2024.
- What is the lowest immunization, hepb3 recorded in North America?
- The lowest recorded value was 0.0% in 1985.
- How does North America rank for immunization, hepb3?
- North America ranks 6th out of 47 groups with data for 2024.
- Is immunization, hepb3 rising or falling in North America?
- Over the last ten years it is up 3.8%. The long-run trend across the full record is volatile.
- Where does this North America data come from?
- The figures come from World Health Organization (WHO), published as part of Immunization, HepB3 (% of one-year-old children). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 40 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.